Boothbay Fund Management »

Disc Medicine shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Disc Medicine (IRON) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Disc Medicine

Tip: Access up to 7 years of quarterly data

All positions including Disc Medicine held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Disc Medicine by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.2M 68k 46.98
2023-06-30 $2.2M 49k 44.40

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr 1 3 Yr Treas Bd Put Option (SHY)
Vmware Cl A Com Call Option
Activision Blizzard
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Sarepta Therapeutics (SRPT)
Cornerstone Strategic Value (CLM)
Zimmer Holdings (ZBH)
Synopsys Put Option (SNPS)
Sprott Physical Gold & Silve Tr Unit (CEF)
Argenx Se Sponsored Adr (ARGX)
Select Sector Spdr Tr Indl Put Option (XLI)
Occidental Pete Corp *w Exp 08/03/202 (OXY.WS)
Elanco Animal Health (ELAN)

View all positions for Boothbay Fund Management

Top funds holding Disc Medicine

Atlas Venture Life Science Advisors
Paradigm Biocapital Advisors
OrbiMed Advisors
Perceptive Advisors
Frazier Life Sciences Management
Vanguard Group
T. Rowe Price Associates
Deerfield Management Company
Henderson Group
Alliancebernstein
Caption Management
5AM Venture Management
Franklin Resources
Citadel Advisors
Ikarian Capital

View all funds holding Disc Medicine